search
Back to results

Efficacy and Safety of Radiofrequency Renal Denervation in Drug Resistant Hypertension

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
Bilateral radiofrequency sympathetic renal denervation
Sponsored by
Tomsk National Research Medical Center of the Russian Academy of Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring Hypertension, Radiofrequency Catheter Ablation, Renal Artery, Sympathetic Nerve Block

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 and ≤ 80 years at time of randomization
  • Informed consent
  • Treatment with full doses of 3 or more anti-hypertensive medications of different classes, of which one is a diuretic.
  • Office Systolic BP (SBP) ≥ 160 mmHg or Diastolic BP (DBP) ≥ 100 mmHg

Exclusion Criteria:

  • An estimated glomerular filtration rate (eGFR) of < 30 mL/min/1.73 m2
  • Ambulatory Blood Pressure Monitoring (ABPM) 24 hour average SBP < 135 mmHg or DBP < 85 mmHg
  • Symptomatic(secondary) hypertension
  • Severe renal artery stenosis or renal arteries abnormalities
  • Individual is pregnant, nursing or planning to be pregnant
  • Severe hepatic dysfunction
  • Any other clinically important renal, hematological, metabolic, neurological, gastrointestinal, hepatic or pulmonary disorders or dysfunctions preventing study participation (investigator's assessment)

Sites / Locations

  • Institute of Cardiology, Siberian Branch of Russian Academy of Medical Sciences

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Renal denervation

Arm Description

All eligible patients undergo bilateral radiofrequency sympathetic renal denervation using endocardial ablation system: after standard renal angiography using femoral access a small size endocardial ablation catheter (5-6 F, 4 mm electrode) is inserted into renal artery and 4-8 point ablations are performed consecutively from distal part to aorta with 3-4 mm step and 90 degrees rotation on the upper, lower, front and back aspects of the artery to get circumferential coverage, then the procedure is repeated on the other side.

Outcomes

Primary Outcome Measures

Change in Office Systolic BP
Number of Serious Adverse Events
A number of first occurrences (within the study period) of any of the following: death, end-stage renal disease, an embolic event resulting in end-organ damage, major bleeding event, renal artery thrombosis, new renal artery stenosis, other serious cardiovascular complications if their relation to the study treatment is assessed at least as possible.

Secondary Outcome Measures

Change in Office Diastolic BP
Change in Mean 24-h Systolic BP
Change in Mean 24-h Diastolic BP
Change in Office Systolic BP
Change in Office Diastolic BP
Change in Mean 24-h Systolic BP
Change in Mean 24-h Diastolic BP
Change in Echocardiographic Left Ventricular Mass
Change in Echocardiographic Left Ventricular Mass
Change in Mean Daytime Systolic BP
Change in Mean Daytime Diastolic BP
Change in Mean Daytime Systolic BP
Change in Mean Daytime Diastolic BP
Change in Mean Nighttime Systolic BP
Change in Mean Nighttime Diastolic BP
Change in Mean Nighttime Systolic BP
Change in Mean Nighttime Diastolic BP
Change in Mean Nighttime Systolic BP Dipping
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Change in Mean Nighttime Diastolic BP Dipping
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Change in Mean Nighttime Systolic BP Dipping
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Change in Mean Nighttime Diastolic BP Dipping
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Change in Daytime Systolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring (ABPM)
Change in Daytime Diastolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Nighttime Systolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Nighttime Diastolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Daytime Systolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Daytime Diastolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Nighttime Systolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Nighttime Diastolic BP Variability
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Change in Serum Creatinine
Change in Serum Creatinine
Change in Serum Creatinine
Change in Casual Proteinuria
Change of protein concentration in morning urine sample
Change in Casual Proteinuria
Change of protein concentration in morning urine sample
Change in Casual Proteinuria
Change of protein concentration in morning urine sample
Change in Specific Gravity of Urine
Change of specific gravity of morning urine sample
Change in Specific Gravity of Urine
Change of specific gravity of morning urine sample
Change in Specific Gravity of Urine
Change of specific gravity of morning urine sample
Change in Renal Resistive Index Measured by Doppler Flowmetry in Left Main Renal Artery
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Change in Renal Resistive Index Measured by Doppler Flowmetry in Right Main Renal Artery
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Change in Resistive Index Measured by Renal Doppler Flowmetry in Left Main Renal Artery
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Change in Resistive Index Measured by Renal Doppler Flowmetry in Right Main Renal Artery
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Change in Ultrasound Intima Media Thickness of Carotid Artery
Change in Ultrasound Intima Media Thickness of Carotid Artery
Change in Arterial Stiffness
Change of cardio-ankle vascular index(CAVI) assessed by vascular screening device VaSera VS1000 (name of the model)
Change in Arterial Stiffness
Change of cardio-ankle vascular index(CAVI) assessed by vascular screening device VaSera VS1000
Change in Morning Surge of BP
Change in Morning Surge of BP

Full Information

First Posted
December 20, 2011
Last Updated
October 4, 2021
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT01499810
Brief Title
Efficacy and Safety of Radiofrequency Renal Denervation in Drug Resistant Hypertension
Official Title
Study of Efficacy and Safety of Radiofrequency Sympathetic Renal Denervation for Treatment of Drug Resistant Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
January 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Single-center, single group study of the efficacy and safety of transcatheter renal denervation for treatment of patients with essential hypertension uncontrolled despite combined pharmacotherapy including 3 or more hypotensive drugs one of which is a diuretic. Bilateral transcatheter renal denervation will be performed on the top of existed pharmacotherapy. Change in blood pressure (BP), left ventricle (LV) mass, carotid artery thickness, renal artery blood flow and renal function, will be assessed at 6 and 12 months of follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension, Radiofrequency Catheter Ablation, Renal Artery, Sympathetic Nerve Block

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
53 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Renal denervation
Arm Type
Experimental
Arm Description
All eligible patients undergo bilateral radiofrequency sympathetic renal denervation using endocardial ablation system: after standard renal angiography using femoral access a small size endocardial ablation catheter (5-6 F, 4 mm electrode) is inserted into renal artery and 4-8 point ablations are performed consecutively from distal part to aorta with 3-4 mm step and 90 degrees rotation on the upper, lower, front and back aspects of the artery to get circumferential coverage, then the procedure is repeated on the other side.
Intervention Type
Procedure
Intervention Name(s)
Bilateral radiofrequency sympathetic renal denervation
Other Intervention Name(s)
Transcatheter renal denervation, Percutaneous radiofrequency ablation of renal nerves
Intervention Description
Bilateral radiofrequency sympathetic renal denervation is performed as percutaneous transluminal radiofrequency (RF) ablation of neural pathways in the renal artery walls and surrounding tissue using standard equipment for RF ablation of cardiac electrical pathways
Primary Outcome Measure Information:
Title
Change in Office Systolic BP
Time Frame
from baseline to 12 months
Title
Number of Serious Adverse Events
Description
A number of first occurrences (within the study period) of any of the following: death, end-stage renal disease, an embolic event resulting in end-organ damage, major bleeding event, renal artery thrombosis, new renal artery stenosis, other serious cardiovascular complications if their relation to the study treatment is assessed at least as possible.
Time Frame
from baseline to 12 months
Secondary Outcome Measure Information:
Title
Change in Office Diastolic BP
Time Frame
from baseline to 12 months
Title
Change in Mean 24-h Systolic BP
Time Frame
from baseline to 12 months
Title
Change in Mean 24-h Diastolic BP
Time Frame
from baseline to 12 months
Title
Change in Office Systolic BP
Time Frame
from baseline to 6 month
Title
Change in Office Diastolic BP
Time Frame
from baseline to 6 month
Title
Change in Mean 24-h Systolic BP
Time Frame
from baseline to 6 months
Title
Change in Mean 24-h Diastolic BP
Time Frame
from baseline to 6 months
Title
Change in Echocardiographic Left Ventricular Mass
Time Frame
from baseline to 6 months
Title
Change in Echocardiographic Left Ventricular Mass
Time Frame
from baseline to 12 months
Title
Change in Mean Daytime Systolic BP
Time Frame
from baseline to 6 months
Title
Change in Mean Daytime Diastolic BP
Time Frame
from baseline to 6 months
Title
Change in Mean Daytime Systolic BP
Time Frame
from baseline to 12 months
Title
Change in Mean Daytime Diastolic BP
Time Frame
from baseline to 12 months
Title
Change in Mean Nighttime Systolic BP
Time Frame
from baseline to 6 months
Title
Change in Mean Nighttime Diastolic BP
Time Frame
from baseline to 6 months
Title
Change in Mean Nighttime Systolic BP
Time Frame
from baseline to 12 months
Title
Change in Mean Nighttime Diastolic BP
Time Frame
from baseline to 12 months
Title
Change in Mean Nighttime Systolic BP Dipping
Description
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Time Frame
from baseline to 6 months
Title
Change in Mean Nighttime Diastolic BP Dipping
Description
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Time Frame
from baseline to 6 months
Title
Change in Mean Nighttime Systolic BP Dipping
Description
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Time Frame
from baseline to 12 months
Title
Change in Mean Nighttime Diastolic BP Dipping
Description
Mean nighttime BP dipping is a relative difference: absolute difference between mean daytime and mean nighttime BP values divided by mean daytime BP value
Time Frame
from baseline to 12 months
Title
Change in Daytime Systolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring (ABPM)
Time Frame
from baseline to 12 months
Title
Change in Daytime Diastolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 12 months
Title
Change in Nighttime Systolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 12 months
Title
Change in Nighttime Diastolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 12 months
Title
Change in Daytime Systolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 6 months
Title
Change in Daytime Diastolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 6 months
Title
Change in Nighttime Systolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 6 months
Title
Change in Nighttime Diastolic BP Variability
Description
daytime/nighttime BP variability is a standard deviation of BP values measured respectively during daytime/nighttime periods in course of ambulatory BP monitoring
Time Frame
from baseline to 6 months
Title
Change in Serum Creatinine
Time Frame
from baseline to 1 week
Title
Change in Serum Creatinine
Time Frame
from baseline to 6 months
Title
Change in Serum Creatinine
Time Frame
from baseline to 12 months
Title
Change in Casual Proteinuria
Description
Change of protein concentration in morning urine sample
Time Frame
from baseline to 1 week
Title
Change in Casual Proteinuria
Description
Change of protein concentration in morning urine sample
Time Frame
from baseline to 6 months
Title
Change in Casual Proteinuria
Description
Change of protein concentration in morning urine sample
Time Frame
from baseline to 12 months
Title
Change in Specific Gravity of Urine
Description
Change of specific gravity of morning urine sample
Time Frame
from baseline to 1 week
Title
Change in Specific Gravity of Urine
Description
Change of specific gravity of morning urine sample
Time Frame
from baseline to 6 months
Title
Change in Specific Gravity of Urine
Description
Change of specific gravity of morning urine sample
Time Frame
from baseline to 12 months
Title
Change in Renal Resistive Index Measured by Doppler Flowmetry in Left Main Renal Artery
Description
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Time Frame
from baseline to 6 months
Title
Change in Renal Resistive Index Measured by Doppler Flowmetry in Right Main Renal Artery
Description
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Time Frame
from baseline to 6 months
Title
Change in Resistive Index Measured by Renal Doppler Flowmetry in Left Main Renal Artery
Description
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Time Frame
from baseline to 12 months
Title
Change in Resistive Index Measured by Renal Doppler Flowmetry in Right Main Renal Artery
Description
Resistive index calculated as relative difference between assessed by ultrasound Doppler maximal and minimal blood flow velocities, i.e. absolute difference between maximal and minimal blood flow velocities divided by maximal flow velocity
Time Frame
from baseline to 12 months
Title
Change in Ultrasound Intima Media Thickness of Carotid Artery
Time Frame
from baseline to 6 months
Title
Change in Ultrasound Intima Media Thickness of Carotid Artery
Time Frame
from baseline to 12 months
Title
Change in Arterial Stiffness
Description
Change of cardio-ankle vascular index(CAVI) assessed by vascular screening device VaSera VS1000 (name of the model)
Time Frame
from baseline to 12 months
Title
Change in Arterial Stiffness
Description
Change of cardio-ankle vascular index(CAVI) assessed by vascular screening device VaSera VS1000
Time Frame
from baseline to 6 months
Title
Change in Morning Surge of BP
Time Frame
from baseline to 12 months
Title
Change in Morning Surge of BP
Time Frame
from baseline to 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 and ≤ 80 years at time of randomization Informed consent Treatment with full doses of 3 or more anti-hypertensive medications of different classes, of which one is a diuretic. Office Systolic BP (SBP) ≥ 160 mmHg or Diastolic BP (DBP) ≥ 100 mmHg Exclusion Criteria: An estimated glomerular filtration rate (eGFR) of < 30 mL/min/1.73 m2 Ambulatory Blood Pressure Monitoring (ABPM) 24 hour average SBP < 135 mmHg or DBP < 85 mmHg Symptomatic(secondary) hypertension Severe renal artery stenosis or renal arteries abnormalities Individual is pregnant, nursing or planning to be pregnant Severe hepatic dysfunction Any other clinically important renal, hematological, metabolic, neurological, gastrointestinal, hepatic or pulmonary disorders or dysfunctions preventing study participation (investigator's assessment)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stanislav E Pekarskiy, MD
Organizational Affiliation
Institute of Cardiology, Siberian Branch of the Russian Academy of Medical Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of Cardiology, Siberian Branch of Russian Academy of Medical Sciences
City
Tomsk
ZIP/Postal Code
634012
Country
Russian Federation

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
Citation
S. Pekarskiy, A. Baev, V. Mordovin, T. Ripp, G. Semke, V. Lichikaki, E. Sitkova, A. Krylov, S. Popov, R. Karpov, Renal denervation by endocardial ablation system, European Heart Journal, Volume 34, Issue suppl_1, 1 August 2013, 3788, https://doi.org/10.1093/eurheartj/eht309.3788
Results Reference
background
PubMed Identifier
26482895
Citation
Ripp TM, Mordovin VF, Pekarskiy SE, Ryabova TR, Zlobina MV, Baev AE, Anfinogenova Y, Popov SV. Predictors of Renal Denervation Efficacy in the Treatment of Resistant Hypertension. Curr Hypertens Rep. 2015 Dec;17(12):90. doi: 10.1007/s11906-015-0603-8.
Results Reference
derived

Learn more about this trial

Efficacy and Safety of Radiofrequency Renal Denervation in Drug Resistant Hypertension

We'll reach out to this number within 24 hrs